American Academy of Neurology (AAN), Neurology, 18(74), p. 1477-1478, 2010
DOI: 10.1212/wnl.0b013e3181d8a414
American Academy of Neurology (AAN), Neurology, 23(73), p. 1957-1962, 2009
DOI: 10.1212/wnl.0b013e3181c5b46d
Elsevier, Year Book of Neurology and Neurosurgery, (2010), p. 39-40
DOI: 10.1016/s0513-5117(10)79238-3
Full text: Download
Background: American Heart Association/American Stroke Association guidelines recommend initiating treatment with IV tissue plasminogen activator (tPA) in acute ischemic stroke patients without suspected coagulopathy prior to availability of clotting results; however, little or no data support this practice. We sought to identify how often blood clotting abnormalities were responsible for withholding IV tPA at our institution.